Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument.J Appl Lab Med. 2020 09 01; 5(5):1107-1110.JA
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
32609341
Citation
Wu, Alan H B.. "Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: a Counterargument." The Journal of Applied Laboratory Medicine, vol. 5, no. 5, 2020, pp. 1107-1110.
Wu AHB. Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument. J Appl Lab Med. 2020;5(5):1107-1110.
Wu, A. H. B. (2020). Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument. The Journal of Applied Laboratory Medicine, 5(5), 1107-1110. https://doi.org/10.1093/jalm/jfaa104
Wu AHB. Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: a Counterargument. J Appl Lab Med. 2020 09 1;5(5):1107-1110. PubMed PMID: 32609341.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument.
A1 - Wu,Alan H B,
PY - 2020/04/27/received
PY - 2020/05/08/accepted
PY - 2020/7/2/pubmed
PY - 2020/9/24/medline
PY - 2020/7/2/entrez
SP - 1107
EP - 1110
JF - The journal of applied laboratory medicine
JO - J Appl Lab Med
VL - 5
IS - 5
SN - 2576-9456
UR - https://www.unboundmedicine.com/medline/citation/32609341/Screening_the_General_Population_for_SARS_CoV_2_Virus_and_COVID_19_Antibodies:_A_Counterargument_
DB - PRIME
DP - Unbound Medicine
ER -